Pediatrics is volume-driven and margin-thin. Vaccine acquisition cost, developmental screening capture, and payer contract terms are the three biggest levers, and they're all measurable.
Every report compares your numbers against published peer data. Sources include MGMA, CMS, and specialty-society reports.
| Metric | Reference value | Source |
|---|---|---|
| Vaccine margin as % of revenue, peds median | 12–18% | MGMA + AAP |
| 96110 billing rate vs. AAP recommended schedule | ~52% capture | AAP study |
| Established visit revenue, peds median | $98–$132 | MGMA 2024 |
You don't need all four. Start with the one we recommend first — most owners stop there because it surfaces enough to act on for the next 90 days.
Ranks your top 8–10 revenue expansion opportunities by specialty, staff, and payer mix.
Specialty-specific coding checklist with commonly missed codes, modifier traps, and a 30-day fix list.
Benchmarks your payer mix against peers and flags the contracts most worth renegotiating.
Identifies whether your NPs, PAs, and licensed staff are billing at full scope.
Pulled from patterns we see across audits. Your numbers will differ, but the categories are remarkably consistent.
Yes. Intake captures your VFC/private split and the report models the margin difference plus group purchasing scenarios.